SEC Form 4 · accession 0001209191-16-138650
INTEGRA LIFESCIENCES HOLDINGS CORP · IART
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Raymond G. Murphy
Director
Period of report
Aug 23, 2016
Accepted (ET)
Aug 25, 2016 · 4:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000917520
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 23, 2016 | M | 2,600 | $21.48 | A | 33,047 | D | |
| Common StockF1 | Aug 23, 2016 | S | 2,600 | $86.6352 | D | 30,447 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $21.48 | Aug 23, 2016 | M | 2,600 | D | — | May 20, 2017 | Common Stock | 2,600 | 2,619 | D |
Explanation of responses
- F1The price shown above represents the weighted average price of the shares sold. The range of sale prices was $86.50 to $86.85.
- F225% of the stock options vest every quarter from the grant date of 05/20/2009.